BBLG Bone Biologics Corporation

Fundamentals / CIK 0001419554 / USD
Other share classes on CIK 0001419554: BBLGW

Bone Biologics Corporation reported $6.43M in total assets and a net loss of $2.84M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BBLG in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$1.06B$528.7M$0-$115.1MFY 2016 Net Income: -$25.88M2016FY 2017 Net Income: -$7.05M2017FY 2018 Net Income: -$4.43M2018FY 2019 Revenue: $1.07BFY 2019 Net Income: -$3.42M2019FY 2020 Revenue: $1.07BFY 2020 Net Income: -$1.82M2020FY 2021 Net Income: -$1.61M2021FY 2022 Net Income: -$1.48M2022FY 2023 Net Income: -$8.95M2023FY 2024 Net Income: -$4.11M2024FY 2025 Net Income: -$3.11M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- -- -- $1.07B $1.07B -- -- --
Research & Development $1.06M $2.13M $6.91M $1.58M $82K $341K $1.10M $104K $1.42M $10.17M
Total Operating Expenses $3.23M $4.22M $9.43M $3.67M $1.10M $825K $2.45M $2.79M $2.63M $20.41M
Operating Income -$3.23M -$4.22M -$9.43M -$3.67M -$1.10M -$825K -$2.45M -$2.79M -$2.63M -$20.41M
EBITDA -- -- -- -- -- -- -$2.45M -$2.79M -$2.63M -$20.41M
Interest Income $122K $56K $1.9K -- -- -- -- -- -- --
Income Before Tax -- -- -- -- -$1.61M -$1.82M -$3.42M -$4.43M -$7.05M -$25.88M
Income Tax Expense -- -- -- -- $1.6K $1.6K $1.6K $1.7K $1.6K $2.2K
Net Income -$3.11M -$4.11M -$8.95M -$1.48M -$1.61M -$1.82M -$3.42M -$4.43M -$7.05M -$25.88M
Basic EPS -$2.65 -$28.96 -$204.26 -$2,957,304.83 -$997,842.17 -$1,796,115.90 -$1,339,959.48 -$2,508,860.31 -$5,160,269.50 -$1,967,174.56
Diluted EPS -$2.65 -$28.96 -$204.26 -$2,957,304.83 -$997,842.17 -$1,796,115.90 -$1,339,959.48 -$2,508,860.31 -$5,160,269.50 -$1,967,174.56
Basic Shares Outstanding 1.2M 253.0K 43.8K 1 2 1 3 2 1 13
Diluted Shares Outstanding 1.2M 253.0K 43.8K 1 2 1 3 2 1 13

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $243K $309K $142K $257K $188K $192K $424K $1.10M
Total Operating Expenses $666K $808K $805K $733K $715K $748K $1.04M $1.55M
Operating Income -$666K -$808K -$805K -$733K -$715K -$748K -$1.04M -$1.55M
Interest Income $48K $35K $39K $48K $47K $6.7K $20K $20K
Net Income -$618K -$774K -$766K -$685K -$667K -$741K -$1.02M -$1.52M
Basic EPS -$0.17 -$0.43 -$0.43 -- -$0.37 -$1.33 -$1.92 --
Diluted EPS -$0.17 -$0.43 -$0.43 -- -$0.37 -$1.33 -$1.92 --
Basic Shares Outstanding 3.7M 1.8M 1.8M -- 1.8M 557.8K 530.6K --
Diluted Shares Outstanding 3.7M 1.8M 1.8M -- 1.8M 557.8K 530.6K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Sep 30
Cash & Cash Equivalents $5.33M $3.33M $3.03M $7.54M $6.68M -- $24K $955K $690K $1.62M
Cash & Short-Term Investments $5.33M $3.33M $3.03M $7.54M $6.68M -- $24K $955K $690K $1.62M
Total Current Assets $5.80M $3.86M $3.74M $8.50M -- -- $31K $1.04M $796K $1.67M
Property, Plant & Equipment, Net -- -- -- -- -- -- -- $50 $146 $170
Total Non-Current Assets $0 $0 $0 $0 -- -- $0 $50 $146 $170
Total Assets $5.80M $3.86M $3.74M $8.50M $6.68M $0 $31K $1.04M $796K $1.67M
Accounts Payable -- -- -- -- -- $465K $43K $125K $217K $225K
Total Current Liabilities $419K $378K $831K $2.55M $100K $13.69M $578K $9.64M $962K $3.82M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $11.32M $0 $8.23M $8.03M
Total Liabilities $419K $378K $831K $2.55M $100K $13.69M $11.90M $9.64M $9.19M $11.85M
Common Stock $1.8K $492 $534 $64 $10K $12K $31K $26K $4.3K $39K
Retained Earnings -$88.13M -$85.02M -$80.91M -$71.96M -$70.48M -$68.86M -$67.04M -$63.62M -$59.19M $56.42M
Total Stockholders' Equity $5.38M $3.48M $2.91M $5.95M $6.58M -$13.69M -$11.87M -$8.60M -$8.40M -$10.18M
Total Equity $5.38M $3.48M $2.91M $5.95M $6.58M -$13.69M -$11.87M -$8.60M -$8.40M -$10.18M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $6.09M $4.03M $4.53M $5.33M $6.05M $6.64M $2.75M $3.33M
Cash & Short-Term Investments $6.09M $4.03M $4.53M $5.33M $6.05M $6.64M $2.75M $3.33M
Total Current Assets $6.43M $4.44M $4.98M $5.80M $6.35M $7.00M $3.16M $3.86M
Total Non-Current Assets $0 $0 $0 $0 $0 $0 $0 $0
Total Assets $6.43M $4.44M $4.98M $5.80M $6.35M $7.00M $3.16M $3.86M
Total Current Liabilities $481K $512K $309K $419K $334K $406K $251K $378K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $481K $512K $309K $419K $334K $406K $251K $378K
Common Stock $3.4K $1.8K $1.8K $1.8K $1.8K $1.7K $3.3K $492
Retained Earnings -$90.29M -$89.67M -$88.90M -$88.13M -$87.45M -$86.78M -$86.04M -$85.02M
Total Stockholders' Equity $5.95M $3.92M $4.67M $5.38M $6.02M $6.60M $2.91M $3.48M
Total Equity $5.95M $3.92M $4.67M $5.38M $6.02M $6.60M $2.91M $3.48M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$3.10M -$4.11M -$8.95M -$1.48M -$1.61M -$1.82M -$3.42M -$4.43M -$7.05M -$25.88M
Depreciation & Amortization -- -- -- -- -- -- $50 $96 $96 $700
Stock-Based Compensation $256K $189K $153K $267K $207K -- $50K $517K $1.62M $4.14M
Operating Cash Flow -$2.69M -$4.12M -$9.56M -$3.57M -$1.23M -$427K -$3.25M -$4.10M -$3.33M -$7.33M
Common Stock Issued $4.35M $1.50M $5.04M $4.43M $6.86M -- -- $4.37M $700K $2.50M
Financing Cash Flow $4.70M $4.42M $5.04M $4.43M $7.90M $403K $2.32M $4.37M $3.40M $6.83M
Net Change in Cash $2.01M $299K -$4.51M $863K $6.68M -$24K -$931K $265K $70K -$495K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$700K -$700K -$800K -$685K -$667K -$741K -$1.02M -$1.52M
Stock-Based Compensation $3.4K $8.3K $24K $46K $87K $73K $51K $101K
Operating Cash Flow -$532K -$518K -$804K -$715K -$591K -$459K -$926K -$1.35M
Common Stock Issued -- -- -- -- -- -- -- $0
Financing Cash Flow -- -- -- $0 $0 $4.35M $348K $1.11M
Net Change in Cash $2.06M -$498K -$804K -$715K -$591K $3.89M -$579K -$241K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- -- -0.1% -0.2% -- -- --
Net Profit Margin -- -- -- -- -- -0.2% -0.3% -- -- --
Return on Equity (ROE) -57.8% -118.0% -307.9% -25.0% -24.5% -- -- -- -- --
Return on Assets (ROA) -53.6% -106.5% -239.4% -17.5% -24.1% -- -11109.8% -425.7% -886.3% -3690.9%
Current Ratio 13.85x 10.22x 4.50x 3.33x -- -- 0.05x 0.11x 0.83x 0.47x
Quick Ratio 12.74x 8.80x 3.64x 2.96x 66.81x -- 0.04x 0.10x 0.72x 0.41x
Revenue Growth (YoY) -- -- -- -- -- 0.0% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -47.8% -73.7% -61.2% -57.8% -65.6% -64.0% -146.5% -118.0%
Return on Assets (ROA) -44.2% -65.2% -57.4% -53.6% -62.1% -60.3% -134.8% -106.5%
Current Ratio 13.38x 8.67x 16.09x 13.85x 19.00x 17.24x 12.59x 10.22x
Quick Ratio 12.66x 7.87x 14.64x 12.74x 18.10x 16.35x 10.94x 8.80x
Source: SEC EDGAR CompanyFacts (CIK 0001419554) · from October 31, 2008 Data through September 30, 2026 · synced Nov 21, 2026, 05:05 UTC · Open in terminal